Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge is advising funds managed by Corsair Capital LLC
Mandate

Vinge is advising funds managed by Corsair Capital LLC

October 03, 2019

Vinge is advising funds managed by Corsair Capital LLC on their acquisition of a controlling interest in Axo AS, a leading consumer credit and loan broker in Scandinavia and Finland.

Vinge has been engaged in regards of Axo Finans’ Swedish operations and worked with teams from Slaughter and May (UK) and BAHR (Norway).

Vinge’s team primarily consisted of partners Christina Kokko (M&A) and Emma Stuart‑Beck (Financial Services) as well as associates Michaela Cronemyr, Marith Welin‑Berger, Hannes Pettersson (M&A), Caroline Krassén and Anton Sjökvist (Financial Services).
 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025